Active Stocks
Tue Mar 19 2024 15:50:19
  1. Tata Consultancy Services share price
  2. 3,977.55 -4.03%
  1. Tata Steel share price
  2. 148.65 -0.64%
  1. Bharti Airtel share price
  2. 1,227.85 0.23%
  1. Power Grid Corporation Of India share price
  2. 258.95 -2.28%
  1. ITC share price
  2. 409.50 -1.89%
Business News/ Politics / Policy/  Covid-19 vaccine: Govt gives grant of 220 crore to boost Covaxin production
BackBack

Covid-19 vaccine: Govt gives grant of ₹220 crore to boost Covaxin production

As a part of this augmentation plan, capacities of Bharat Biotech Limited, Hyderabad as well as other public sector manufacturers are being upgraded with required infrastructure and technology, according to a statement from the Ministry of Science and Technology

A health worker administers a dose of Covaxin, at Govt Sarvodaya Bal Vidyalaya, Rani Jhansi Road, in New Delhi (HT)Premium
A health worker administers a dose of Covaxin, at Govt Sarvodaya Bal Vidyalaya, Rani Jhansi Road, in New Delhi (HT)

The central government today said that in order to accelerate the development and production of indigenous Covid vaccines and to augment the capacity of indigenous production of Covaxin under the Mission, the Department of Biotechnology, Government of India in April, 2021 provided financial support as grant to vaccine manufacturing facilities for enhanced production capacities, which is expected to reach more than 10 crore doses per month by September, 2021.

"As a part of this augmentation plan, capacities of Bharat Biotech Limited, Hyderabad as well as other public sector manufactures are being upgraded with required infrastructure and technology. Financial support is being provided as grant from GoI to the tune of approximately 65 crore to Bharat Biotech’s new Bangalore facility which is being repurposed to increase the capacity of vaccine production.," according to a statement from the Ministry of Science and Technology.

This is being implemented by Department of Biotechnology, Govt. of India at Biotechnology Industry Research Assistance Council (BIRAC), New Delhi

The following three public sector companies are also being supported to increase the capacity of vaccine production:

1. Haffkine Biopharmaceutical Corporation Ltd, Mumbai-a State PSE under State Govt of Maharashtra.

Financial support of Rs. 65 crores as grant from GoI is being provided for this facility to make it ready for manufacturing. The facility will have a capacity of 20 million doses per month, once functional.

2. Indian Immunologicals Limited (IIL), Hyderabad –A facility under National Dairy Development Board is being provided a grant of Rs. 60 crore and

3. Bharat Immunologicals and Biologicals Limited (BIBCOL), Bulandshahr a CPSE under Department of Biotechnology, Government of India is being supported with a grant of Rs. 30 crores to prepare their facility to provide 10-15 million doses per month.

Further, Gujarat Biotechnology Research Centre, Department of Science and Technology Govt. of Gujarat along with Hester Biosciences and OmniBRx has also firmed up its discussions with Bharat Biotech to scale up the COVAXIN technology and to produce minimum 20 million doses per month. Technology transfer agreement have been finalized with all manufacturers.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Politics News and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 15 May 2021, 03:25 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App